The FDA continues its efforts to curb the proliferation of products claiming to contain cannabidiol and marketed as treatments for acute and chronic pain.
NOVEMBER 13, 2019
NOVEMBER 13, 2019
The FDA continues its efforts to curb the proliferation of products claiming to contain cannabidiol and marketed as treatments for acute and chronic pain.